Click to join the Growin investment community!

Davita inc.DVA.US Overview

US StockHealthcare
(No presentation for DVA)

DVA Overall Performance

METRIC
VALUE
vs. INDUSTRY
EPS
11.70
PE Ratio
12.51
Forward PE
11.19
PS Ratio
0.75
PB Ratio
-
Price-to-FCF
7.65
Gross Margin
32.54%
Net Margin
6.35%
Revenue Growth (YoY)
5.09%
Profit Growth (YoY)
4.53%
3-Year Revenue Growth
4.91%
3-Year Profit Growth
7.10%

DVA AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

DVA Current Performance

1.27%

Davita inc.

-0.47%

Avg of Sector

-0.64%

S&P500

DVA Key Information

DVA Financial Forecast

chart

Browsing restrictions can be lifted for a fee.

QuarterlyEPS ForecastQoQMaxMin
2025Q1
2025Q2
2025Q3
2025Q4
2026Q1

DVA Earnings Table

Unit : USD

QTRNon-GAAP EPSEPS YoYEPS Surprise %SalesSales YoYSales Surprise %NPM
Current
2024Q4
2024Q3
2024Q2
2024Q1

DVA Profile

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company provides disease management services to 16,000 patients in risk-based integrated care arrangements and 7,000 patients in other integrated care arrangements; vascular access services; clinical research programs; physician services; and comprehensive kidney care services. As of December 31, 2021, it provided dialysis and administrative services in the United States through a network of 2,815 outpatient dialysis centers serving approximately 203,100 patients; and operated 339 outpatient dialysis centers located in 10 countries outside of the United States serving approximately 39,900 patients. Further, the company provides acute inpatient dialysis services in approximately 850 hospitals and related laboratory services in the United States. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.

Price of DVA

DVA FAQ

  • When is DVA's latest earnings report released?

    The most recent financial report for Davita inc. (DVA) covers the period of 2025Q2 and was published on 2025/06/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating DVA's short-term business performance and financial health. For the latest updates on DVA's earnings releases, visit this page regularly.

  • Where does DVA fall in the P/E River chart?

    According to historical valuation range analysis, Davita inc. (DVA)'s current price-to-earnings (P/E) ratio is 12.01, placing it in the Value zone on the P/E River chart. This level indicates that the market's expectations for future earnings are already reflected in the share price, with the valuation currently leaning conservative. Investors are advised to further examine the company's fundamentals and its position in the industry cycle to validate whether the valuation is justified.

  • What is the operating profit of DVA?

    According to the latest financial report, Davita inc. (DVA) reported an Operating Profit of 530.48M with an Operating Margin of 15.7% this period, representing a growth of 5.9% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.

  • How is DVA's revenue growth?

    In the latest financial report, Davita inc. (DVA) announced revenue of 3.38B, with a Year-Over-Year growth rate of 6.05%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.

  • How much debt does DVA have?

    As of the end of the reporting period, Davita inc. (DVA) had total debt of 12.82B, with a debt ratio of 0.73. Long-term debt comprises a higher/lower proportion. The level of financial leverage directly impacts the company's capital structure and interest coverage. If debt is high, pay attention to interest expenses and refinancing risks. Conversely, a low-leverage structure indicates greater risk tolerance but potentially less growth flexibility.

  • How much cash does DVA have?

    At the end of the period, Davita inc. (DVA) held Total Cash and Cash Equivalents of 796.96M, accounting for 0.05 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does DVA go with three margins increasing?

    In the latest report, Davita inc. (DVA) achieved the “three margins increasing” benchmark, with a gross margin of 33.1%%, operating margin of 15.7%%, and net margin of 5.9%%. This demonstrates improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess DVA's profit trajectory and future growth potential.

  • Is DVA's EPS continuing to grow?

    According to the past four quarterly reports, Davita inc. (DVA)'s earnings per share (EPS) shows a steady growth trend, with the latest EPS at 2.62. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.

  • What is the FCF of DVA?

    Davita inc. (DVA)'s Free Cash Flow (FCF) for the period is 203.15M, calculated as Operating Cash Flow minus Capital Expenditures, representing a fall of 69.87% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.